UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

: AnafranilRet-75mg-Tablet-SE-IS-APD - XML Representation

Raw xml | Download



<AdministrableProductDefinition xmlns="http://hl7.org/fhir">
  <id value="AnafranilRet-75mg-Tablet-SE-IS-APD"/>
  <meta>
    <profile
             value="http://unicom-project.eu/fhir/StructureDefinition/PPLAdministrableProductDefinition"/>
  </meta>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: AdministrableProductDefinition AnafranilRet-75mg-Tablet-SE-IS-APD</b></p><a name="AnafranilRet-75mg-Tablet-SE-IS-APD"> </a><a name="hcAnafranilRet-75mg-Tablet-SE-IS-APD"> </a><a name="hcAnafranilRet-75mg-Tablet-SE-IS-APD-en-US"> </a><p><b>status</b>: Active</p><p><b>formOf</b>: <a href="MedicinalProductDefinition-AnafranilRet-75mg-Tablet-SE-IS-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100012657-00010568,http://ema.europa.eu/fhir/eurdId#811; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Prolonged-release tablet; indication = Egentlig depression med melankoli. Djupa eller långvariga egentliga depressioner utan melankoli.  Paniksyndrom med eller utan agorafobi. Agorafobi. Tvångstillstånd. Associerade symtom vid  narkolepsi (speciellt kataplexi, sömnparalys och hypnagoga hallucinationer). Idiopatiskt smärtsyndrom  med depressiva symtom.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = N06AA04</a></p><p><b>administrableDoseForm</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000000004 100000073683}">Prolonged-release tablet</span></p><p><b>producedFrom</b>: <a href="ManufacturedItemDefinition-AnafranilRet-75mg-Tablet-SE-IS-MID.html">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Prolonged-release tablet; unitOfPresentation = Tablet</a></p><h3>RouteOfAdministrations</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Code</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000073345 100000073619}">Oral use</span></td></tr></table></div>
  </text>
  <status value="active"/>
  <formOf>🔗 
    <reference
               value="MedicinalProductDefinition/AnafranilRet-75mg-Tablet-SE-IS-MPD"/>
  </formOf>
  <administrableDoseForm>
    <coding>
      <system value="https://spor.ema.europa.eu/v1/lists/200000000004"/>
      <code value="100000073683"/>
      <display value="Prolonged-release tablet"/>
    </coding>
  </administrableDoseForm>
  <producedFrom>🔗 
    <reference
               value="ManufacturedItemDefinition/AnafranilRet-75mg-Tablet-SE-IS-MID"/>
  </producedFrom>
  <routeOfAdministration>
    <code>
      <coding>
        <system value="https://spor.ema.europa.eu/v1/lists/100000073345"/>
        <code value="100000073619"/>
        <display value="Oral use"/>
      </coding>
    </code>
  </routeOfAdministration>
</AdministrableProductDefinition>